Prognostic Factors for Survival and Relapse in ANCA-Associated Vasculitis with Renal Involvement: A Clinical Long-Term Follow-Up Study

Aim. We describe the clinical pattern of ANCA-associated vasculitis (AAV) and assess long-term prognostic factors of patients and renal survival and relapse. Methods. Data from 85 patients with renal biopsy-proven AAV at a single center with up to 20-year [median 16.2 years (95% CI 14.9-17.7)] follo...

Full description

Bibliographic Details
Main Authors: Anna Salmela, Tom Törnroth, Tuija Poussa, Agneta Ekstrand
Format: Article
Language:English
Published: Hindawi Limited 2018-01-01
Series:International Journal of Nephrology
Online Access:http://dx.doi.org/10.1155/2018/6369814
id doaj-6f6aa2835eac48ed953ba2de1a499057
record_format Article
spelling doaj-6f6aa2835eac48ed953ba2de1a4990572020-11-25T01:09:31ZengHindawi LimitedInternational Journal of Nephrology2090-214X2090-21582018-01-01201810.1155/2018/63698146369814Prognostic Factors for Survival and Relapse in ANCA-Associated Vasculitis with Renal Involvement: A Clinical Long-Term Follow-Up StudyAnna Salmela0Tom Törnroth1Tuija Poussa2Agneta Ekstrand3Department of Internal Medicine, Vaasa Central Hospital, Vaasa, FinlandDepartment of Pathology, Helsinki University Hospital, Helsinki, FinlandSTAT-Consulting, Nokia, FinlandAbdomen Center, Nephrology, Helsinki University Hospital, Helsinki, FinlandAim. We describe the clinical pattern of ANCA-associated vasculitis (AAV) and assess long-term prognostic factors of patients and renal survival and relapse. Methods. Data from 85 patients with renal biopsy-proven AAV at a single center with up to 20-year [median 16.2 years (95% CI 14.9-17.7)] follow-up were retrospectively collected. Results. Overall, 55% of the patients had microscopic polyangiitis (MPA) and 45% had granulomatosis with polyangiitis (GPA). The histopathological classes were focal in 35%, crescentic in 26%, mixed in 20%, and sclerotic glomerulonephritis in 19% of the patients. As induction treatment, a combination of cyclophosphamide and corticosteroids was given to 82%, while a combination of azathioprine and corticosteroids was maintenance therapy in 79%. The twenty-year patient survival was 45%. In a multivariable analysis, age ≥58 years [hazard ratio (HR) 7.64, 95% CI 3.44-16.95] and myeloperoxidase (MPO) ANCA (HR 2.12, 95% CI 1.08-4.17) were associated with shorter patient survival time. Renal survival was 68% overall: 88% in focal, 71% in crescentic, 56% in mixed, and 37% in sclerotic class (p=0.01). Female sex (HR 0.26, 95% CI 0.10-0.73) was a predictor of improved renal survival, whereas GFR <30 ml/min and MPO-ANCA were associated with worse renal survival (HR 4.10, 95% CI 1.35-12.49 and HR 3.10, 95% CI 1.21-7.95, respectively). Relapse-free survival at 20 years was 10%. MPA was associated with a lower risk for relapse (HR 0.48, 95% CI 0.28–0.82). Conclusion. We confirmed the improved patient and renal survival in AAV patients with glomerulonephritis, while relapse remained the primary challenge. Histopathological classification may be relevant for survival.http://dx.doi.org/10.1155/2018/6369814
collection DOAJ
language English
format Article
sources DOAJ
author Anna Salmela
Tom Törnroth
Tuija Poussa
Agneta Ekstrand
spellingShingle Anna Salmela
Tom Törnroth
Tuija Poussa
Agneta Ekstrand
Prognostic Factors for Survival and Relapse in ANCA-Associated Vasculitis with Renal Involvement: A Clinical Long-Term Follow-Up Study
International Journal of Nephrology
author_facet Anna Salmela
Tom Törnroth
Tuija Poussa
Agneta Ekstrand
author_sort Anna Salmela
title Prognostic Factors for Survival and Relapse in ANCA-Associated Vasculitis with Renal Involvement: A Clinical Long-Term Follow-Up Study
title_short Prognostic Factors for Survival and Relapse in ANCA-Associated Vasculitis with Renal Involvement: A Clinical Long-Term Follow-Up Study
title_full Prognostic Factors for Survival and Relapse in ANCA-Associated Vasculitis with Renal Involvement: A Clinical Long-Term Follow-Up Study
title_fullStr Prognostic Factors for Survival and Relapse in ANCA-Associated Vasculitis with Renal Involvement: A Clinical Long-Term Follow-Up Study
title_full_unstemmed Prognostic Factors for Survival and Relapse in ANCA-Associated Vasculitis with Renal Involvement: A Clinical Long-Term Follow-Up Study
title_sort prognostic factors for survival and relapse in anca-associated vasculitis with renal involvement: a clinical long-term follow-up study
publisher Hindawi Limited
series International Journal of Nephrology
issn 2090-214X
2090-2158
publishDate 2018-01-01
description Aim. We describe the clinical pattern of ANCA-associated vasculitis (AAV) and assess long-term prognostic factors of patients and renal survival and relapse. Methods. Data from 85 patients with renal biopsy-proven AAV at a single center with up to 20-year [median 16.2 years (95% CI 14.9-17.7)] follow-up were retrospectively collected. Results. Overall, 55% of the patients had microscopic polyangiitis (MPA) and 45% had granulomatosis with polyangiitis (GPA). The histopathological classes were focal in 35%, crescentic in 26%, mixed in 20%, and sclerotic glomerulonephritis in 19% of the patients. As induction treatment, a combination of cyclophosphamide and corticosteroids was given to 82%, while a combination of azathioprine and corticosteroids was maintenance therapy in 79%. The twenty-year patient survival was 45%. In a multivariable analysis, age ≥58 years [hazard ratio (HR) 7.64, 95% CI 3.44-16.95] and myeloperoxidase (MPO) ANCA (HR 2.12, 95% CI 1.08-4.17) were associated with shorter patient survival time. Renal survival was 68% overall: 88% in focal, 71% in crescentic, 56% in mixed, and 37% in sclerotic class (p=0.01). Female sex (HR 0.26, 95% CI 0.10-0.73) was a predictor of improved renal survival, whereas GFR <30 ml/min and MPO-ANCA were associated with worse renal survival (HR 4.10, 95% CI 1.35-12.49 and HR 3.10, 95% CI 1.21-7.95, respectively). Relapse-free survival at 20 years was 10%. MPA was associated with a lower risk for relapse (HR 0.48, 95% CI 0.28–0.82). Conclusion. We confirmed the improved patient and renal survival in AAV patients with glomerulonephritis, while relapse remained the primary challenge. Histopathological classification may be relevant for survival.
url http://dx.doi.org/10.1155/2018/6369814
work_keys_str_mv AT annasalmela prognosticfactorsforsurvivalandrelapseinancaassociatedvasculitiswithrenalinvolvementaclinicallongtermfollowupstudy
AT tomtornroth prognosticfactorsforsurvivalandrelapseinancaassociatedvasculitiswithrenalinvolvementaclinicallongtermfollowupstudy
AT tuijapoussa prognosticfactorsforsurvivalandrelapseinancaassociatedvasculitiswithrenalinvolvementaclinicallongtermfollowupstudy
AT agnetaekstrand prognosticfactorsforsurvivalandrelapseinancaassociatedvasculitiswithrenalinvolvementaclinicallongtermfollowupstudy
_version_ 1725178370908487680